Concept information
Preferred term
BBIBP-CorV
Definition
- BBIBP-CorV is one of two inactivated virus COVID-19 vaccines being developed by Sinopharm. As of December 2020, it is in Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. By November, nearly one million people had taken the vaccine through China's emergency use program. (Wikipédia)
Broader concept
Creator
- Patricia Fener
In other languages
-
French
URI
http://data.loterre.fr/ark:/67375/C0X-ZZSTX1BQ-P
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}